CLOVER HEALTH INVESTMENTS, CORP. CEO Vivek Garipalli receives $390M in 2021

CLOVER HEALTH INVESTMENTS, CORP. reports 2021 executive compensation

By ExecPay News

Published: August 12, 2022

CLOVER HEALTH INVESTMENTS, CORP. reported fiscal year 2021 executive compensation information on August 12, 2022.

In 2021, six executives at CLOVER HEALTH INVESTMENTS, CORP. received on average a compensation package of $90M, a 942% increase compared to previous year.

Average pay of disclosed executives at CLOVER HEALTH INVESTMENTS, CORP.

Vivek Garipalli, Chief Executive Officer, received $390M in total. 100% of Garipalli's compensation, or $390M, was in stock awards.

Andrew Toy, President, received a compensation package of $142M, which increased by 1548% compared to previous year. 100% of the compensation package, or $141M, was in stock awards.

Jamie L. Reynoso, Chief Operating Officer, earned $3M in 2021.

Prabhdeep Singh, Chief Growth Officer, received $2.7M in 2021.

Mark C. Herbers, Chief Financial Officer, earned $1M in 2021.

Joseph Wagner, Chief Financial Officer, received $407K in 2021.